If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.
Published: November 30, 2021 at 11:10AM
from NYT Health https://ift.tt/3lnhk2t
If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.
Published: November 30, 2021 at 11:10AM
from NYT Health https://ift.tt/3lnhk2t